These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 1900320

  • 1. Comparison of the luteolytic action of gonadotrophin-releasing hormone antagonist and cloprostenol, and the ability of human chorionic gonadotrophin and melatonin to override their luteolytic effects in the marmoset monkey.
    Webley GE, Hodges JK, Given A, Hearn JP.
    J Endocrinol; 1991 Jan; 128(1):121-9. PubMed ID: 1900320
    [Abstract] [Full Text] [Related]

  • 2. Roles of cyclic AMP and inositol phosphates in the luteolytic action of cloprostenol, a prostaglandin F2 alpha analogue, in marmoset monkeys (Callithrix jacchus).
    Michael AE, Webley GE.
    J Reprod Fertil; 1993 Mar; 97(2):425-31. PubMed ID: 8388957
    [Abstract] [Full Text] [Related]

  • 3. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM, Nestor JJ, Vickery BH.
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [Abstract] [Full Text] [Related]

  • 4. Regulation of the corpus luteum of early pregnancy in the marmoset monkey: local interactions of luteotrophic and luteolytic hormones in vivo and their effects on the secretion of progesterone.
    Hearn JP, Webley GE.
    J Endocrinol; 1987 Aug; 114(2):231-9. PubMed ID: 3477610
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Changing responsiveness of luteal cells of the marmoset monkey (Callithrix jacchus) to luteotrophic and luteolytic agents during normal and conception cycles.
    Webley GE, Richardson MC, Summers PM, Given A, Hearn JP.
    J Reprod Fertil; 1989 Sep; 87(1):301-10. PubMed ID: 2560061
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of an LHRH antagonist on gonadotrophin and oestradiol secretion, follicular development, oestrus and ovulation in Holstein heifers.
    Rieger D, Roberge S, Coy DH, Rawlings NC.
    J Reprod Fertil; 1989 May; 86(1):157-64. PubMed ID: 2502618
    [Abstract] [Full Text] [Related]

  • 11. Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.
    Valbuena D, Pellicer A, Guanes PP, Remohí J, Simón C.
    Hum Reprod; 1997 Oct; 12(10):2118-22. PubMed ID: 9402265
    [Abstract] [Full Text] [Related]

  • 12. Luteolysis induced by a luteinizing hormone-releasing hormone agonist is prevented by human chorionic gonadotropin.
    Bergquist C, Nillius SJ, Wide L.
    Contraception; 1980 Oct; 22(4):341-7. PubMed ID: 7004772
    [Abstract] [Full Text] [Related]

  • 13. Role of luteinizing hormone in the expression of cholesterol side-chain cleavage cytochrome P450 and 3 beta-hydroxysteroid dehydrogenase, delta 5-4 isomerase messenger ribonucleic acids in the primate corpus luteum.
    Ravindranath N, Little-Ihrig L, Benyo DF, Zeleznik AJ.
    Endocrinology; 1992 Nov; 131(5):2065-70. PubMed ID: 1425410
    [Abstract] [Full Text] [Related]

  • 14. Functional evidence for divergent receptor activation mechanisms of luteotrophic and luteolytic events in the human corpus luteum.
    Ottander U, Leung CH, Olofsson JI.
    Mol Hum Reprod; 1999 May; 5(5):391-5. PubMed ID: 10338360
    [Abstract] [Full Text] [Related]

  • 15. Cloprostenol-induced luteolysis in the marmoset monkey (Callithrix jacchus).
    Summers PM, Wennink CJ, Hodges JK.
    J Reprod Fertil; 1985 Jan; 73(1):133-8. PubMed ID: 3968650
    [Abstract] [Full Text] [Related]

  • 16. Direct and indirect inhibition of ovulation in rats by an antagonist of luteinizing hormone-releasing hormone.
    Nekola MV, Coy DH.
    Endocrinology; 1985 Feb; 116(2):756-60. PubMed ID: 3917910
    [Abstract] [Full Text] [Related]

  • 17. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Corpora lutea induced by gonadotrophin-releasing hormone treatment of anoestrous Welsh Mountain ewes: reduced sensitivity to luteinizing hormone in vivo and to chorionic gonadotrophin in vitro.
    Bramley TA, Stirling D, Menzies GS, Baird DT.
    Reproduction; 2005 Jan; 129(1):61-73. PubMed ID: 15615899
    [Abstract] [Full Text] [Related]

  • 20. Effects of an LH-releasing hormone antagonist on the secretion of LH, FSH, prolactin and ovarian steroids at different stages of the luteal phase in the stumptailed macaque (Macaca arctoides).
    Fraser HM, Abbott M, Laird NC, McNeilly AS, Nestor JJ, Vickery BH.
    J Endocrinol; 1986 Oct; 111(1):83-90. PubMed ID: 3097236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.